Our findings revealed the relationships between TPM3 mRNA in the platelets and the metastasis of BC cells, and the TPM3 mRNA in the platelets can be exploited as biomarkers for early diagnosis of metastatic BC, thereby extending the life expectancy of patients with BC. This evidence concerns the gene TPM3 and breast cancer.